COMPASS Pathways appoints new finance chief
- COMPASS Pathways (NASDAQ:CMPS) has appointed Michael Falvey as Chief Financial Officer, suceeding Piers Morgan, effective 1 January 2022.
- Michael Falvey, most recently served at Karyopharm Therapeutics (NASDAQ:KPTI), where he led the financial strategy and prepared the financial infrastructure to support commercial operations as the company delivered pivotal clinical data and prepared to commercialise its first product.